“Allogeneic Hematopoietic Cell Transplant For Hiv Patients With Hematologic Malignancies: The Bmt Ctn-0903/amc-080 Trial.”. Biol Blood Marrow Transplant 25 (11). Biol Blood Marrow Transplant: 2160-2166. doi:10.1016/j.bbmt.2019.06.033.
. 2019. “Blood And Marrow Transplant Clinical Trials Network Report On The Development Of Novel Endpoints And Selection Of Promising Approaches For Graft-Versus-Host Disease Prevention Trials.”. Biol Blood Marrow Transplant 24 (6). Biol Blood Marrow Transplant: 1274-1280. doi:10.1016/j.bbmt.2018.01.002.
. 2018. “Three Prophylaxis Regimens (Tacrolimus, Mycophenolate Mofetil, And Cyclophosphamide; Tacrolimus, Methotrexate, And Bortezomib; Or Tacrolimus, Methotrexate, And Maraviroc) Versus Tacrolimus And Methotrexate For Prevention Of Graft-Versus-Host Disease With”. Lancet Haematol 6 (3). Lancet Haematol: e132-e143. doi:10.1016/S2352-3026(18)30221-7.
. 2019.